ArticleInnovation (Cambridge (Mass.))2025

Famitinib plus camrelizumab in patients with advanced colorectal cancer: Data from a multicenter, basket study.

Luoyan Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.